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Abstract 
Trace minerals are a group of nutritional elements appearing in low concentrations in 
body tissues. These minerals may have both regulatory and structural functions in the 
body, and therefore play an important role in human health and well being. Many of 
these elements have psychiatric actions, including lithium, copper and zinc. Lithium is 
the most commonly prescribed psychoactive trace mineral, as this is the current 
preferred treatment for bipolar disorder. 
The research presented in this thesis has focused on the psychoactive nutritional trace 
minerals, copper and zinc and how they interact with lithium to affect glioblastoma cell 
proliferation, function and viability in vitro. Two different glioblastoma cell lines 
(U87M0 and 132 1N1) were cultured in media containing different concentrations of 
either zinc or copper above and below the physiological range (0.02 to 10 mgIL copper 
or 0.2 mg/L to 10 mgIL zinc), in the absence and presence of lithium (1 mg/L). 
Cell viability was determined using tryptan blue staining. Proliferation rate was 
determined using both visual counting and an MTT (Methyithiazol tetrazolium) cell 
proliferation assay. Cell morphology was measured using a standard Harris 
haematoxylinl eosin-y morphology stain and a computer software package. Cell 
function was determined by evaluation of cellular resting potential 
A comparison of two proliferation assays used in this study revealed the MTT assay to 
be the most accurate and precise. At trace mineral concentrations up to 7.5 mg/L, there 
were no dose dependent effects of either zinc or copper on cell proliferation, with or 
without lithium in the culture media. However, at a supraphysiological trace mineral 
concentration (10 mgIL), U87MG cells appeared to be tolerant to zinc, but sensitive to 
copper which resulted in marked reductions of cell number (2.91% of control), and cell 
II 
viability (24.36% of control). However, 1321N1 cells appeared sensitive to both 
supraphysiological zinc and copper concentrations with cell viability reduced to 73.63% 
and 68.63% of control, respectively. 
Zinc uptake by 132 1N1 cells appears to be highly regulated, and intracellular zinc levels 
detected using a fluorescent probe were not changed b extracellular medium 
concentrations of zinc up to 10 mgIL. This tight regulation was perturbed by treatment 
of cells with therapeutià (1 mgIL) levels of lithium. These results indicate an interaction 
between lithium and zinc in cell culture which may be of clinical interest if reproducible 
in other cell types. 
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CHAPTER 1 
INTRODUCTION 
1.1 Psychoactive trace minerals 
The Austin Nutritional Research group, Texas define trace minerals as; "minerals that 
occur in tiny amounts or traces. They play a major role in health, since even minute 
portions of them can powerfully affect health. They are essential in the assimilation and 
utilization of vitamins and other nutrients." These minerals have a wide range of 
biological activities, predominantly predicted by influences they have on hormonal and 
enzymatic activity within biological systems. 
This group, the 'trace elements' include aluminium, arsenic, bromide, boron, caesium, 
calcium, chromium, cobalt, copper, iron, iodine, lead, lithium, magnesium, manganese, 
potassium, rubidium, scandium, selenium and zinc. The sale of forms of these as 
nutritional supplements to aid health, both mental and physical is a large and lucrative 
modem business and many of these do have significant health benefits, although many 
exceed the recommended uptake. Some elements have been more extensively 
researched than others, and found to have marked psychological or physiological 
effects. The best known of the trace minerals to be used in treatment of illness is 
lithium. The efficacy of lithium in treatment of bipolar disorder is well documented and 
it continues to be the preferred method of treatment 2 . 
Many of the other trace minerals have been demonstrated to have psychological effects 
and may interact with lithium. In schizophrenia, a disorder which can often have a 
similar presentation to bipolar disorder, levels of the trace elements cerium, indium, 
copper, boron, vanadium and zinc have been found to decrease, while the 
concentrations of manganese, calcium, caesium. and scandium increase 3 . Chromium has 
also been found to potentiate antidepressant treatment for dysthymic disorder in a 
limited number of patients observed in one trial 4 
Lithium carbonate treatment has been shown to specifically alter serum concentrations 
of some trace elements. Cobalt, potassium, iron, vanadium and rubidium have been 
found to decrease with increasing levels of lithium, but aluminium and bromide have 
been found to increase with increasing lithium 5. The relationships between these 
elements within the periodic table and within enzymatic reactions within biological 
systems may provide some indication of modes of action of lithium prophyaxis. 
Selenium and zinc have been found to have effects in a variety of disorders, including 
Alzheimer's disease, depression and hostile behaviour patterns. Patients with 
Alzheimer's' brains have been found to contain only 60% of the amount of selenium 
found in the brains of healthy subjects 6. In addition, diminished selenium concentrations 
were associated with a depressed mood status and an increase in hostile behaviour in a 
group of young men living in a research compound 7. Zinc concentrations in plasma 
have been shown to fall in Alzheimer's disease and in both unipolar depression and 
schizophrenia, both of which are often related to bipolar disorder 6 . 
Haepatic zinc levels have been shown to rise in lithium treatment 8. Zinc is found in 
presynaptic vesicles, release from which is dependent on neural activity. Zinc has 
therefore been proposed as an indicator of neural injury in a variety of brain diseases, 
and is therefore likely to be particularly interesting to study in vitro. 9 
Plasma copper concentration has been found to be reduced in depressed patients, 
irrespective of treatment levels and observed effectiveness of the treatment, and has 
therefore been proposed as a 'trait marker' for depression' ° . Copper-dependent 
ri 
enzymes play a vital role in cellular respiration and in the catecholamine biosynthetic 
pathway. Copper is therefore likely to influence neural cell development and activity" 
Several trace mineral cations have been shown to have a regulatory effect on the action 
of the N-methyl-D-aspartate (NMDA) receptor in excitable cells. NIMDA receptors are 
one of the 3 groups of the glutamate family of receptors. These receptors are permeable 
to calcium ions and are important to synapse plasticity 12 , vital to learning and injury 
recovery processes within the brain' 3 . These receptors can be blocked by either 
magnesium or zinc ions. The ions of calcium, magnesium, zinc, aluminium and lithium 
have all been shown to have effects on NMDA receptor activity and to have interactive 
effects' 4
. Zinc, mercury, aluminium and lead have also been found to alter activity of 
voltage-activated calcium channels, but not sodium or potassium channels in excitable 
neural cells' 5 . 
Some heavy metal complexes have also been found to have influences on the Gamma 
Amino Butyric Acid (GABA) receptor-channel complex. Mercuric chloride has been 
shown to augment GABA-induced current, while copper and zinc complexes suppress 
GABA-induced current' 6 . GABA is a major inhibitory neurotransmitter in the central 
nervous system (CNS), inhibition of which can lead to seizures. Drugs with positive 
modulation of GABA receptor activity are very effective in seizure control and used in 
treatment of epilepsy.' 7 
The above overview indicates that many trace elements have been shown to be 
psychoactive. The following review will focus on lithium, the most ubiquitous element 
in the treatment of neuropsychiatric disorders, and its interaction with two other trace 
elements of clinical importance, copper and zinc. In order to understand the efficacy 
and importance of lithium as a drug, it is first important to understand bipolar disorder, 
the illness for which it is most commonly prescribed. 
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1.2 Bipolar disorder 
Bipolar disorder is a euthymic disorder featuring a cycling of mood state between a 
state of 'mania' and one of 'depression'. Onset is often in adolescence, with atypical 
features present in early, or adolescent bipolar disorder and the speed of cycle 
increasing with the number of previous cycles experienced. 
The manic phase can last anywhere between 2 weeks and 4-5 months, the median 
duration being about 4 months. The manic phase may be prolonged by the existence of 
a prodrome (hypomania) 18 . The prodrome may last around 2-3 weeks, and usually 
features increased consumption of alcohol, disturbed sleep patterns, and milder forms of 
the symptoms of mania. Change between phases of the disorder and onset of a cycle 
may follow stressful circumstances, however, symptoms may vary betweeh days with 
no external influences, and a diurnal variation in presentation is also commo& 9 . 
Common features of the manic phase include increases in thought speed, physical 
activity, sociability, talkativeness and sexual energy; along with elevated mood state, 
over-familiar behaviour, and a decreased perceived need for sleep. Other symptoms 
may appear to be similar to those of schizophrenia, and may cloud diagnosis, especially 
if the prodrome or hypomanic state has not been observed. These include 
hallucinations, delusions, ideas of persecution and irritable or boorish behaviour. A 
manic phase may disrupt all aspects of a patients life, but can be pleasurable to the 
patient and lead to great creative achievements (for example Handel's Messiah and 
some of Virginia Woolf's writings) 20 This pleasurability can lead to non-compliance 
with medication which may initiate relapse into the manic-depressive cycling 21 . 
A depressive phase may last around 6 months, and shows many of the symptoms of 
unipolar depression. Common somatic symptoms of the depressive state include 
ri 
anhedonia, emotional unreactivity, psychomotor retardation or agitation, loss of appetite 
and weight, reduced libido, and disturbed sleep patterns that lead to early waking (at 
least 2 hours early) and a greater degree of depression in the mornings. Other common 
features include a loss of self-esteem, a shortening of attention span, feelings of 
pessimism, and guilty thoughts that often lead to thoughts or actions of self-harm or 
suicide, frequently in the form of overdosing. 
Adolescent patients may also show other symptomatic features of manic depression 
including anxiety, irritability, excessive alcohol consumption, phobias, obsessive 
behaviours and hypochondria. These symptoms may appear more prominently than 
those mentioned above 22 . 
There are many subclasses of the depressive state, which may be classified as being 
with or without somatic symptoms, (four or more somatic symptoms must be featured 
to be classified as "with"). Somatic symptoms may be mild, moderate or severe, and if 
severe, may be with or without psychosis. 
Mild depression features; a depression of mood state, along with anhedonia and 
increased fatiguability, and must feature two others of the symptoms listed above. 
Moderate depression should feature at least two symptoms of mild depression, plus 
three to four others. Symptoms are often marked if the range of them is limited, and an 
episode should last 2 or more weeks. 
Severe depression almost always features somatic symptoms and loss of self-esteem. 
Feelings of guilt and attempts of self-harm or suicide are also common features of 
severe depression. Cycling of severe depression may also be referred to as recurrent 
depressive disorder. 
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Severe depression may also feature symptoms of psychosis, often including auditory or 
visual hallucinations commonly featuring accusatory or defamatory voices, or visions of 
rotting flesh or waste. A patient experiencing severe depression with psychotic 
symptoms may also believe that the loss of a loved one or family member, or world 
disasters in current affairs are caused by unrelated activities of their own, or that unless 
they perform certain ritualistic behaviours disasters will befall themselves or those close 
to them.' 9 
Cycling between these two states of mania and depression may disrupt all aspects of 
patients' lives - work, home and social. Severe, unpredictable mood swings and 
distorted beliefs about self and others can result in loss of jobs, friends and family, 
leading to isolation and loss of self worth, compounding symptoms of the disorder. 
Rapid diagnosis and accurate treatment is therefore essential. 
Some patients with bipolar disorder may show neuropsychological impairment, and it 
has been suggested that a higher level of impairment may indicate a poorer prognosis 
for the disorder 23 . Neuropsychological impairment symptoms often resemble those of 
schizophrenia, but are generally less severe. The symptoms shown vary between stages 
of bipolar disorder. Patients in a depressed state demonstrate impairment in frontal lobe 
function, while patients in a manic state show impairment in discriminatory and verbal 
learning skills 24 . The reason for a poor prognosis among neuropsychologically 
impaired patients is not clear. 
1.3 Lithium. 
Effective treatment of bipolar disorder using lithium carbonate (also called Carbolith or 
Lithane) was first recorded by John Cade in 1940. Initial treatment of symptoms is 
usually acute and vigorous in order to control symptoms, followed by a gradual 
reduction in additional treatments to provide a chronic stabilisation. Lithium carbonate, 
the most ubiquitous form of therapy for bipolar disorder patients, is defined as a "mood 
stabiliser" and may be used in conjunction with other treatments such as reuptake 
inhibitors, eletroconvulsive therapy (ECT), carbamazepine (tegretol), divalproex, 
thyroxine (to counteract a major side effect of lithium prophylaxis; hypothyroidism), 
lamotrigine, gabapentin, and atypical antipsychotics. Response to each form of 
treatment may vary between patients and is dependent on many factors, primarily 
compliance with treatment. However, the stage of cycle, number of previous cycles and 
rate/symptoms of cycles have all been suggested as possible predictors of response. 
Level of response to treatment with lithium carbonate is often evident within 
approximately one week of commencement of treatment, but other treatments may have 
a longer period of latency. Carbamazepine, for example, may take up to 10 to 14 days. 
There have been many theories as to how lithium actually acts to stabilise mood. One 
of the current theories is that lithium influences calcium levels in the intracellular 
space25 . Inositol trisphosphate (1P3) is the second messenger molecule responsible for 
calcium release from storage within cellular organelles. The final stage of the recycling 
process of 1P3 involves the enzyme inositol monophosphatase, which controls the levels 
of 1P3 and controls mood swings. The initiation of action of inositol monophosphatase 
is dependent upon the action of 2 magnesium ions on receptors. Lithium acts by 
mimicking magnesium, with which it has a very similar charge: size ratio. Lithium thus 
blocks the Mg receptors on inositol monophosphatase and prevents the breakdown of 
1P3, interrupting the re-absorption of calcium. 
Lithium may act to inhibit many phosphatases, as shown in figure 1, but its action is 
most potent on inositol monophosphatase. 1P3 can also play a role in proliferation 
control and ffinction of cells, and thus lithium's disruption of P3 breakdown may be of 
interest in proliferation studies 26 . 
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Figure 1. The phosphoionositide cycle, including the synthesis and metabolism of 
multiple second messengers. 
Lithium affects many of the enzymes involved as shown in figure 1 above. 
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1.3.1 Variability in patient response to Lithium therapy. 
Response to lithium treatment can be variable between bipolar disorder patients. One 
study has compared 3 teclmiques of assessment of lithium responsivity and efficacy. 
The 3 studies compared were: 
. Discontinuation teclmique, in which patients treated with lithium have has their 
treatment discontinued, and the reoccurrence of symptoms recorded 27 . This 
method may, however, result in withdrawal effects. 
• Before and after observations of lithium prophylaxis effects 28, this may be 
inaccurate owing to the cyclic nature if this disorder. 
• Placebo studies 29
. This study appears the most reliable but is still prone to 
inaccuracies rising from assessment of a cyclic psychiatric disorder 
Each of these studies confirmed the existence of responders and non-responders to 
lithium prophylaxis. Cooper found a non-significant proportion of patients improved 
following lithium prophylaxis compared to placebo, but the only patients to display no 
symptoms were those receiving lithium treatment. This supports the hypothesis that 
some patients do respond to lithium prophylaxis and others do not, however for those 
who do not respond, there is no similarly effective alternative treatment at the present 
time30 . 
Many studies have been carried out in order to find a method of predicting the 
responsivity of patients to lithium prophylaxis. Patients with a greater cognitive 
impairment appear to have a poorer prognosis than those of minimal or no 
impairment23 , but other indicators have also been proposed. Response to auditory 
evoked potentials has been suggested as a predictor of responsivity to treatment, as has 
11 
phosphocreatine response to photic stimulation. A reduced response to photic 
stimulation in treatment resistant patients has been found 31 
1.3.2 Side effects of lithium therapy. 
Lithium prophylaxis may carry side effects, including electroencephalographic 
abnormalities associated with an increase in bromide and vanadium levels 32 , alterations 
in levels of other trace elements, and hypothyroidism 33 ' 34 
Hypothyroidism may confound results of lithium efficacy studies, as thyroid activity 
may affect mood. This means that lithium, unless used in conjunction with thyroxine, 
can help to contribute to the symptoms it is intended to treat 35 . Hypothyroidism has 
been observed to affect 2-5% of lithium patients, particularly ladies aged between 35 
and 55 (14% women, 4.5% men). Thyroid screening and advice is therefore 
recommended for all potential lithium patients 21 . 
1.3.3 Interactions between lithium and other trace minerals. 
The action of lithium illustrated in figure 1 is dependent upon the ability of lithium to 
interact with, and mimic other trace minerals. However, other interactions are also 
apparent. 
Bromide has been proposed as a lithium activity potentiator, possibly enhancing effects 
of lithium in the human body. Bromide is therefore likely to have a role in the degree of 
responsivity a patient shows to lithium prophylaxis. However, Handorf et al have 
suggested that elevated serum bromide may actually be due to altered renal thnction 
shown to occur with high levels of lithium 36 
It has been proposed that rubidium nfay have a synergistic interaction with lithium as 
they both appear in the same group of the periodic table. Combined treatment with 
12 
lithium and lead has been shown to correlate with a decrease in serum arsenic levels, 
and red blood cell transport of vanadium, rubidium and caesium has also been shown to 
be altered with differing levels of lithium 37 . 
Many of the trace elements studied, including copper, iron, selenium, chromium, cobalt 
and zinc, can influence immune function 31 . It has been suggested that immune function 
may play a role in the responsivity to lithium prophylaxis 38 . Cytokines, such as 
interleukin-6, lymphocytes and killer cells, have all been shown to be altered in mental 
disorders such as unipolar depression, melancholia and schizophrenia 39, and in altered 
trace element status 40 . Lithium has also been shown to influence activity of the immune 
system. In humans, evidence has been found that at above normal therapeutic levels, 
lithium can increase the synthesis of immunoglobulins by B-lymphocytes, proliferation 
of T-lymphocytes and phagocytotic activity of macrophages 41 . Some work is being 
carried out as to uses of this function of lithium in the treatment of autoimmune 
deficiency syndrome (AIDS) 42 . It is, therefore, possible that it is immune system status, 
not trace element status that is affected in bipolar disorder, and it is here that differences 
should be sought in patients taking lithium. Trace mineral status, therefore, may play a 
key role in the response to lithium treatment. 
1.4 Zinc 
Zinc is a group II alkali metal forming tetrahedral compounds. It has a molecular 
weight of 65.37, and an atomic number of 30. Zinc is found in amino acids and 
nucleotides, and has a particular affinity for electron rich thiol, hydroxyl and nitrogen 
groups. Good dietary sources of zinc include red meat, shell fish, chicken, egg and 
whole grain43 . Zinc is the second most prevalent trace mineral in the human body, 
following iron. There are approximately 3 grammes of zinc in the human body, 
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predominantly located within the bone, muscle, and liver. Most (90%) of the zinc in the 
brain is bound in metal-protein complexes 44 . 
Zinc is important in many biological systems, including 
transcription factor binding, regulation of tubulin polymerisation, 
• activity of zinc-dependent enzymes (including alkaline phophatase, superoxide 
dismutase and lymphocyte S'nucleotidase), 
biomembrane formation, 
. stabilization of RNA, DNA, ribosomes and hormone receptors for a number of 
hormones (including somatomedin, prolactin, thyroid hormone, corticosterone, 
leuteinizing hormone, folicle stimulating hormone and hormone releasing 
hormone). 
Clinical and severe zinc deficiency in humans may result in: 
general tissue dysilinction leading to dermatitis, 
• decreasing spermatogenesis in males, 
• abnormalities of bone growth, 
• parturition difficulties and birth defects resulting from deficient cell division, 
• degradation of insulin which leads to poor glucose tolerance and increased lipid 
oxidation, 
• suboptimal cellar immune fUnction (reduction in number of killer cells, 
lymphocytes and neutrophils) 
1.4.1 Psychoactive prope flies of zinc. 
Animal studies have revealed that dietary zinc deficiency may result in behavioural 
changes. Feeding can become cyclic (possibly as an adaption to falling zinc levels) but 
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anorexia may also be seen. Noradrenaline levels increase, and the hypothalamus 
reduces in size and function. The loss of growth and brain function may partly be 
explained by the alteration of feeding habits, but exceeds levels filly explained by food 
reduction and must be specific to zinc depletion". These effects can be seen very 
shortly after removal of zinc from the diet, as the functional zinc pool is small and may 
fall to less than 1/2 of the original pool in 12 hours or less. 
In humans, zinc levels have also been shown to be altered in a variety of disorders. 
Zinc and albumin levels fall in unipolar depression, and lowered zinc in schizophrenia 
is proposed to have importance for neurotransmitter signalling 40. Zinc appears to be 
involved in excitatory signalling, and in the modulation of inhibitory GABA. Zinc 
therefore, may contribute to seizures, and the reduction in zinc in schizoaffective 
disorders may be an adaptive response to excessive excitation of neurones in these 
illnesses3 ' 6 . 
Haepatic zinc levels have been shown to rise in treatment with lithium 5. This lends 
credence to the theory that reduction in zinc in psychiatric disorders may be an adaptive 
response to excessive excitability. A recent double-blind placebo controlled study has 
also demonstrated a possible role for zinc as a supplementary medication in the 
treatment of Attention Deficit.Hyperactivity Disorder (ADHD) among 4-11 year old 
out-patients. This is proposed to be due to a regulation of the dopamine signal pathway, 
which is associated with pleasure and reward sensations 45 . This finding contradicts the 
theory that zinc is involved in neurone excitability, and thus seizures and mania, as 
increasing zinc reduces hyperactive behaviour amongst young people. 
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1.5 Copper 
Copper has 3 ionic valencies: Cu which is very insoluble and complexed, Cu 3 which 
is very rare, and Cu 2 
 which is the most common and has 3 types in enzymes. Type I 
appears in oxidases, and is a deep blue colour. Type II is found in multicopper 
oxidases, is not coloured, but can be detected by electron parallel resonance (EPR). 
Type III is neither blue in colour or detectable by EPR. 
The best food sources of copper are shellfish, nuts, seeds, legumes, bran, liver and organ 
meats46
. According to the World Health Organisation , the average Western diet 
contains less than the reference nutrient intake' 9 . However, clinical symptoms of 
deficiency are rarely seen. Total body copper levels are lower than those of other trace 
minerals such as zinc and iron (50-120 mg on average) and it is primarily stored in the 
liver, bound to metallothionine and other proteins. 
Most copper absorbance occurs in the small intestine, with some in the stomach 
Copper is carried by saturable active transport on ceruloplasmin carrier proteins or 
albumin to storage sites. There is also a small amount of passive diffusion. Most serum 
copper is bound to ceruloplamsin, while remaining copper is bound to albumin, 
metallothionein or other proteins 47. Concentrations of copper stored in the liver is 
regulated by metallothionine. The main excretory route for copper is through the 
gastrointestinal tract, although other excretory routes may play a minor role. Copper 
may interact with other dietary constituents such as iron, zinc, molbydenum, ascorbic 
acid, carbohydrates, phyate, fibre and some drugs 11 . Copper occurs in many enzymes, 
including amine oxidases such as monoamine oxidase, diamine oxidase, lysys oxidase 
and PAM, ferroxidases I and II, cytochrome c oxidase, dopamine a hydroxylases, 
superoxide dismutase and tyrosinase. 
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There are several features of copper deficiency, and each can be explained by alterations 
in copper-dependent enzyme activity. For example: 
damage to coimective tissue may be observed, due to reduction of cross linking 
of collagen and elastin and lysyl oxide, as lysyl oxidase is a copper-dependent 
enzyme. 
• altered iron metabolism, leading to anaemia due to the altered activity of the 
copper-dependent enzymes ceruplasmin and ferroxide II oxidase decolouration 
of skin and hair following altered tyrosinase activity on melanin. Increased 
cholesterol levels are found in animal studies, although this effect is not found in 
humans. 
Altered thermal regulation, glucose metabolism, blood clotting, pro and antioxidant 
function and immune function may also be associated with copper deficiency'. T cells 
appear to be more sensitive to copper depletion than B cells 48 . There appears to be a 
greater potential for cellular damage by calcium following impaired antioxidant activity 
and mitochondrial activity in copper deficiency. 
1.11 Psychoactive properties of copper. 
Copper deficiency also has some central nervous system effects. Cytochrome c oxidase 
is involved in the formation of myelin from phospholipids, thus the activity of this 
enzyme may influence the speed of neurotransmission. Monoamine oxidase inhibitors 
act as effective antidepressants, the copper dependency of monoamine oxidase may 
have implications for mood in copper deficiency. Copper is also a constituent of an 
enzyme involved in dopamine to noradrenaline conversion 11 . Copper has been found to 
be elevated in depressed patients, and antidepressant treatment has no effect on copper 
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levels. Copper has therefore been proposed as a trait marker for depression t0 . Plasma 
copper concentration has also been found to be depleted in schizophrenia 3 and increased 
in lithium treatment associated with diabetes, although it is unchanged in diabetes 
alone5 . 
1.6 Glial cells 
Much research has been done into the roles of neural cells in brain development and 
illness. However, little work has been done on the role of glial cells in mental illness. 
There are 50 times as many glial cells in the human brain as there are neurones; and 
they play important roles in the protection, support and nutrition of neurones. 
Figure 2. A tynical astrocyte 49 
Current research is demonstrating that the astrocyte, a common brain glial cell (figure 2) 
has many more roles, and greater importance than had been previously thought. These 
cells appear to interact with neurones, affecting their ability to signal with each other. 
This suggests that they may influence the learning, thinking and development processes 
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of the brain. 50 
 Astrocytes are the cells in the central nervous system which can divide 
and reproduce, and it is because of this action that they may cause tumours 51 . Glial 
cells have been shown to play a role in the regulation of the neural medium by taking up 
neurotransmitters and ions 50
. These cells may, therefore have good control of trace 
minerals and remain unaffected in their proliferation and function by medium trace 
mineral status. 
1.6.1 Cell culture as an animal model 
The use of cell culture techniques has been proposed as a more accurate and less 
ethically contentious method of modelling human responses to medication than animal 
models alone. Cells suitable for culture lines tend to be immortal (either of tumour 
origin, or foetal origin) and thus do not stop dividing and growing with age or crowding. 
Cultured non-immortalised cells can provide a very accurate prediction of the action of 
normal cells. 
For example, the Physicians Committee for Responsible Medicine (PCRM), in an 
article entitled 'new cell tests beat animal tests' cite results presented at the Conference 
of the Scandinavian Society for Cell Toxicology in which rat LD50 tests (the dose level 
of a chemical required to kill 50% of rats tested) were compared with human cell tests. 
In this test, the rat LD50 test was found to have a 59% accurate prediction of effects, 
while human cell test accuracy was found to be 77% with one cell line, or 80% when 
tested with 3 different cell lines and results combined. 
Much work is being carried out, searching for methods of enhancement of longevity for 
cultured cells, in order to improve their range of uses. Immortalization may be carried 
out by the action of some viruses or by the use of cancerous cells. Either method may 
alter the features of cells to a greater or lesser extent compared to normal in vivo cells52 
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Drugs are now also being developed and tested without the use of animal models 
because of developments in cell culture teelmique. Several companies have ceased the 
use of animal experimentation in favour of cell culture use for non-prescription drugs 
(Gillette and Mary Kay UK), and others are seeking to develop prescription drugs 
without animal testing (Pharmagene Laboratories, with Glaxo Wellcome, SmithKline 
Beecharn and Shire Pharmaceuticals, UK) 53 . 
The cell lines used in this study were 1321N1 and U87MG. These are glioblastoma 
multiforme/astrocytoma cells, taken from human tumour patients, subcultured and used 
in many cell biology studies within the Biomedical Research Unit at the University of 
Central Lancashire, and in many other research facilities. 
1.6.2 How closely do glioblastoma mu!4forme cells mimic healthy glial cells? 
Glial cells are defined as; "A type of cell that surrounds nerve cells and holds them in 
place. Glial cells also insulate nerve cells from each other" 54 . A glioblastoma 
multiforme is defined as; "A type of brain tumour that forms from glial (supportive) 
tissue of the brain. It grows very quickly and has cells that look very different from 
normal cells. It is also called grade IV astrocytoma." (National Cancer Institute, UK) 55 . 
There are 4 grades of glioma, each increasing in level of malignancy and morphological 
difference from healthy cells. A grade IV glioma is the most morphologically different 
to normal glial/astrocyte cells and, thus the most aggressive and difficult to treat form of 
glial tumour. 56 The differences occur for the genetic reasons outlined below. 
1.6.3 The genetic alterations ofglioblastoma multiforme. 
Different grades and strains of Glioblastoma multiforme may have different genetic 
changes, the most common genetic alterations, however, include; 
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• p53, a tumour suppressor gene is frequently altered, inhibiting its activity and 
thus promoting excessive proliferation. 
• Epidermal growth factor receptor (EGFR) gene, this gene controls cell 
proliferation and is amplified or over-expressed in over one third of 
glioblastoma. 
• MDM2 is often over expressed in glioblastoma, this binds to p53, blocking its 
action, thus de-regulating cell proliferation. 
• Platelet-derived growth factor (PDGF) gene acts as a mitogen for glial cells 
when bound to the PDGF receptor, this receptor is often amplified or over-
expressed in glioblastoma. 
PTEN encodes a tyrosine phosphatase. Phosphatases turn off signalling which is 
dependent on phosphorylation. Genetic alterations in PTEN, common in glioblastoma 
multiforme, can cause continuous signalling of these pathways, and thus cause 
excessive proliferation 57 . 
The 1321N1 cell line has been shown to have the stereotypical p53 protein mutation, as 
well as the presence of a c-myc oncogene, featuring t(8;14) chromosomal translocation. 
The genetic mutations of U87MG are not listed. 58 
All of these alterations are related to an inhibition of the down-regulation of cell 
division, and proliferation of this cell line compared to healthy glial cells. While 
glioblastoma cell lines can genetically differ from healthy glial cells in a number of 
ways, and should not, therefore, be used as a definitive image of healthy glial cell 
development, they may well give a useful indication of likely alterations with treatment. 
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1.7 Assessment of cell proliferation 
Previous research investigating in vitro cell culture conditions on cell proliferation and 
viability have employed a number of different methods. This section provides a brief 
overview of these methods with a review of their strengths and weaknesses. 
1.7.1 Trypan Blue staining 
Trypan Blue is an established stain to study cell proliferation and viability. Cells are 
lifted from the base of their flask, homogenised, stained with trypan blue solution, and 
subsequently, they are counted manually by use of a haemocytometer. Viability is 
discernable from the level of staining in each cell. Viable cells do not allow entry of 
trypan blue and appear white under the microscope, but non-viable cells appear dark 
blue in colouration. This method is time-consuming and open to researcher bias in cell 
counting. Cells on the edge of the haemocytometer grid may be differentially counted 
and cells may clump together even following homogenisation, making accurate 
counting difficult. Several research companies are currently searching to produce more 
accurate, reproducible methods of obtaining the same data. Trypan Blue staining, 
however remains the technique to which new assays are compared. 596061  
1. 7.2 Visual counting 
Visual counting is the simplest method of testing cell proliferation. Cells are grown, 
and then counted under a light microscope using a graticule. The key problems with 
this method are those associated with achieving a high degree of accuracy when cell 
populations are confluent, and cells tend to grow in homogenous clumps. Therefore, 
the selection of a section of cover-slip that is not representative of the population is 
major source of error. Efforts to minimise these sources of error must be considered if 
this technique is used. 
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1.7.3 Methylthiazol tetrazoliun, (MTT) counting 
MTT is a water-soluble compound which is reduced to a non water soluble purple 
formazan by the action of dehydrogenases. Dehydrogenases are a large class of enzyme 
responsible for many of the reductive reactions within biology' 2 . Different cells may 
contain different levels of dehydrogenase enzymes, but all can be expected to have 
some reductive enzyme. All cell types can, therefore, be expected to have a differently 
shaped calibration curve. The resulting formazan can then be solubilized using Sodium 
dodecyl sulphate (SDS), and concentration measured by optical absorbance at 550 nm 
wavelength. 
Cells are grown in a 96-well plate for this method, and absorbance read using a plate-
reader. This method claims accuracy up to approximately 106 
 cells per well, but can be 
confounded by the enzyme glutathione S-transferase (OST), which also reduces Mn. 
This method only counts viable cells, level of viability and presence of non-viable cells 
is not shown62 . This assay is routinely used owing to its accuracy and ease of use. It 
can be used in conjunction with Trypan Blue counting to provide and accurate image of 
proliferation and viability. 6 ' 
1.7.4 Protein assay. 
This method is based on the principle that the protein content of a cell pellet is 
proportional to the number of cells in that pellet. Cells grown in medium can be lifted 
from the base of a flask and then centrifuged to form a pellet of cells. Protein content 
can be determined by a number of different methods. 
The micro-Lowry protein assay kit was used in this study. The Lowry protein assay 
was first used to measure total protein content of samples in 195 163  , and remains one of 
the two more frequently used protein assays to date, the other being the Bradford 
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protein assay. 64 
 The Lowry assay is dependent upon the complexing of copper with 
protein in alkaline conditions, folin phenol reagent (phospho-molybdic-phosphotungstic 
reagent) then binds to the protein and is reduced, changing colour from yellow to blue. 
Optical absorbance is then measured at 650 nm. There is a variation in colour between 
protein types, a similar protein to those to be measured should be used for a calibration 
curve65 . In the research presented in this thesis, the proteins assayed were common to 
cells, thus the use of a general protein standard was appropriate. The chemicals 
barbital, CAPS, caesium chloride, citrate, cyteine, diethanolamine, dithiothreitol, 
EDTA, EGTA, HEPES, mercaptoethanol, Nonidet P-40, phenol, polyvinyl pyrrolidone, 
sodium deoxycholate, sodium salicaylate, thimerosol, tricine, TRIS and Trition X-100 
may all interfere with the Lowry assay results but there is no reason to believe that 
levels of these compounds will vary between treatment groups of the cells used in this 
study65 
The Bradford protein assay was developed in 1972, and has fewer chemical 
interferences than the Lowry assay. It is dependent upon Coomassie Blue 0-250 
binding to proteins and darkening in colour 66. This produces a linear relationship 
between protein content and absorbance at 595 nm, in the range 5-25 sg/mL67. A 
variance in colour production depending on protein type occurs in this assay, and 
calibration should be made with similar protein type to the protein to be measured. 
1.8 Assessment of cell function 
1.8.1 Morphology 
Cell morphology can be quantified by measuring a number of parameters including 
process number and length, nuclear diameter and area and cell body diameter and area. 
Visualisation is aided by the use of a morphological stain, such as the Harris 
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hematoxylin stain, which differentially stains nuclear and cytoplasmie structures. 
Measurements of morphological parameters can then be made by use of a Spot 4.2.3 for 
windows software package (see section 2.8). 
1.8.2 Ion transport. 
Transport of zinc into cells can be monitored using zinc-specific fluorescent markers, 
of which several are available. These markers allow for imaging of cells and 
localisation of zinc ions within the cell as well as quantitative analysis of zinc 
influx68 , 69, 70
. In this study, zinc concentration and localisation were measured using 
Furazin-1, a highly zinc-specific fluorescent marker. 
1.8.3 Electrical activity of cells 
All cells which regulate ion levels in their cytoplasm have a 'resting potential'. This is 
the charge difference in resting cells between the interior of the cell, using ATP to 
create and maintain ion gradients and the exterior of the cell. This potential difference 
can be measured by impaling a cell with a fine glass electrode filled with an electrically 
conductive solution. 
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Figure 3. The ion distribution of a typical excitable cell (cat motor neurone. 
The resting membrane potential of a cell is the product of the ionic distribution across 
the plasma, and the selective permeability of the plasma to those ions 71 . The resting 
membrane potential, therefore, gives an indication of ion pump activity and membrane 
cohesion. In the cell illustrated in figure 3, the intracellular space has a negative charge 
compared to the extracellular fluid. This encourages positive ions (sodium and 
potassium) to enter the cell and negative ions chloride to leave the cell. The ionic 
concentration gradient also pushes sodium into the cell, but acts against the potential 
gradient for potassium and sodium. Electrical and concentration gradients in this case 
are not equal, and produce net forces on the ion. Active ion transport must occur to 
maintain this resting potential. 
Expected resting potentials for excitable cells (neurones and muscle fibres) are in the 
-50 to -60 my range, however, non-excitable cells (including glial cells) may have a 
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lower resting potential as sodium, potassium action potential formation are not part of 
their function. Excitable cells and in vivo preparations are more commonly tested for 
resting potential level than non-excitable cultured cells, however impalement of non-
excitable cells is possible. 
Potential differences may be affected by temperature changes of the medium in which 
cells are maintained, cell cluster size and correct impalement of the cells. An excessive 
hole diameter may rupture cells, thus removing any resting potential 72 . Some metal 
ions, such as copper, lead, silver, mercury, zinc and cadmium have been shown to 
influence conductance and permeability of excitable cell membranes, exceeding those 
expected by the alteration of charge associated with addition of ions. This may be due 
to metal ion receptors on the surface of cells, or competition for calcium binding sites 
within NMDA receptors and other cellular structures 73 . 
1.9 The project aims and hypothesis 
The human diet is often associated in popular science with many disorders including 
those of mood, attention and learning. The sale of dietary supplements in the form of 
vitamins, mineral and trace elements is a common and lucrative business and there is 
scientific support to the idea that intake of certain elements may influence brain 
activity74 . A number a trace minerals have been shown to influence psychiatric or 
physiological functions of human subjects, however, two have been selected for this 
study: zinc and copper. Previous research has indicated that these two minerals are 
likely to have roles in psychiatric illnesses through their effect on cellular respiration 
and proliferation. This study used cell lines of glial cells to observe the effects of 
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varying physiological concentrations of trace minerals, in the absence and presence of 
lithium to observe effects on growth, development and function. 
Hypothesis 
Interactions between lithium and other trace minerals alter cell proliferation and 
function within the brain. This in turn affects the prognosis for bipolar disorder patients 
undergoing treatment with lithium salts. 
The aims of this study were therefore 
1. to study alterations in cell morphology, growth, division and signalling within 
trace mineral normal and enhanced cell culture medium 
2. to observe whether these parameters are altered by either the presence or 
absence of therapeutic levels of lithium 
CHAPTER 2 
MATERIALS AND METHODS 
2.1 Materials 
Media ingredients, trypsin, salt solution, trace mineral salts, trypan blue, plastics, micro-
Lowry protein assay kit and poly-l-orinithine were obtained from Sigma-Aldrich 
Company Limited, Fancy Road, Poole, Dorset, BH12 4QH. 
The MTT assay kit and zinc fluorescent probe were obtained from Molecular Probes 
Europe By, Pootgebouw, Rijinsburgerweg 102333 AA Leiden, the Netherlands. 
Glass used for the microelectrodes was obtained from Harvard Apparatus Ltd, Fircroft 
Way Edenbridge, Kent TN8 61-TB. 
Cell lines U87MG and 1321N1 were donated to the Biomedical Research Unit (BRU) 
at the University of Central Lancashire by Dr Jaleel Miyan, University of Manchester 
Institute of Science and Technology (UMIST). 
2.2 Medium 
Cells were grown in Dulbecco'sModified Eagles Medium (DMEM). The medium was 
made to contain 20 gm L-glutamine, 100 units penicillin, 0.1 mg streptomycin and 2.5 
tg amphotericin-B per mL, diluted in DMEM (composition of DMEM as supplied is 
shown in appendix 1). 10% total solution volume of Foetal Bovine Serum (FBS) was 
then added. This mixture was sterile filtered (2 gm mesh bottle-top filter with vacuum 
pump) and stored in a sterile bottle in a refrigerator. 
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Media supplemented with trace mineral salts had a solution of these salts added in the 
filtration stage measured on a chemical balance and suspended in minimum volume 
deionised sterile water to ensure full transfer of salt. Concentration and volume of salt 
solution added was low enough to produce an unchanged osmolarity. 
2.3 Trace mineral status 
Concentrations of zinc and copper in the medium were assessed by Atomic Absorption 
Spectroscopy (Iinicam 929 AA spectrometer). Media were then supplemented to test 
levels of either zinc or copper in either the presence or absence of 1 mgJL (0.07 mM) 
lithium (therapeutic serum level = 0.6 mg/L-1.2 mgfL (0.043 mM - 0.086 mM)). 
Medium not supplemented with additional zinc, copper or lithium was the control 
condition. 
Test concentrations were: 
For Zinc 	 For Copper 
Control= 0.227 mg/L 3.47iM 
	 Control 0.024 mg/L 0.38 gM 
0.5 mg/L 7.65 pM 0.1 mgfL 1.57 pM 
1.0 mg/L 15.29 pM 0.5 mg/L 7.87 pM 
5.0 mg/L 76.45 jiM 1.0 mg/L 15.73 jiM 
7.5 mg/L 114.68 jiM 5.0 mg/L 78.68 jiM 
10.Omg/L 152.91 jiM 10.Omg/L 157.37 jiM 
Lithium levels of control medium were negligible. 
Salts used for the supplementation of test media were copper (11) sulphate (CuSO4 
RMM 159.61), zinc sulphate (ZnSO4 •7H20 RMIM 287.54) and lithium sulphate 
(Li2SO4. H20 RMIM 127.96). 
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These salts were selected for use as sulphates are used in other copper and zinc cell 
culture studies 75 ' 76 
2.4 Ccli lines 
IJ87MG and 132 INI cells were stored in liquid nitrogen in a medium of 0.3 ml PBS, 
0.6 ml DMEM, and 0.1 nil Dimethyl Sulphoxide (DMSO). Rate of freezing of cells 
was controlled using isopropyl alcohol, in order to prevent cell lysis due to water 
crystallisation in fast freezing or cell death due to cytotoxicity of DMSO. 
When required, cells were warmed in sterile water in a water bath maintained at 36°C 
and placed into a sterile cell culture flask (base surface area 25 cm 2) with 7 ml DMEM 
overnight, to promote adhesion to the flask base. Medium was then changed in order to 
counteract the cytotoxic effects of DMSO. 
Cells were incubated in a 5 % CO2, 95 % air, 37°C humidified incubator (Sanyo). All 
solutions coming into contact with the cells were warmed to 37°C in a water-bath prior 
to contact. 
Medium was changed every 2 days or as needed to maintain glucose levels 
distinguishable by the colouration change of medium from pink to yellow as glucose is 
utilised by cells. 
2.5 Sub-culturing 
When cells became confluent in a flask, they were sub-cultured. Over confluence of 
cells can lead to cell death and confound results. 1321N1 cells needed sub-culturing 
within 7 days of seeding, but were found to be at a good confluence level for counting 
at 3 days. U87M0 cells needed sub-culturing within 14 days of seeding but were found 
to be at a good confluence level for counting at 7 days. 
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Cells were washed twice in Hanks Balanced Salt Solution and then lifted from the 
bottom of the flask by incubation in 1 ml!25 cm 2 trypsin EDTA solution (0.25 %) for 5 
mm.. After this period, any un-detached cells were detached by tapping the flask or, if 
necessary, use of a sterile cell scraper. A volume of 2 ml! 25 cm 2 medium was then 
added to counteract any toxic effects of trypsin. An aliquot of 100 jil of this solution 
was then mixed 1:1 with trypan blue solution. Cell number was then calculated using a 
1 jil haemocytometer under a light microscope (Leica, 20 x magnification). Living cells 
did not take in the dye and thus appeared white under the microscope, dead cells 
appeared dark blue in colour. 4 counts were taken, and the mean of these counts used, 
and 25 x 104 living cells/ cm 3 were added to a new cell culture flask using the 
calculation: - 
Volume of cell 	 - 
suspension containing ZZ 25xl0 viable cells 
Desired number 
Required volume = 	 25x 10 	 of cells 
Average cell count x 2 x104 i 	 To yield number of 
cells per ml suspension 
Number of cells in 	 Following 1:1 dilution of cell 
haemocytometer volume 	 suspension with trypan blue 
(lO4rnl) 
Enough of the required medium was then added to each flask to cover the cells (7 ml 
approx). 
2.6 Cell count methods 
Three different methods of counting cell were used in this study, they included: 
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26.1 Trypan Blue Counting. 
Cells were grown in a 25 cm 2 base area cell culture flask. Cells were lifted from the 
base of the flask by washing twice with HBSS, followed by 5-10 minute incubation at 
37°C in 1 ml 0.25% trypsin. Any cells not lifted at this point were either lifted by 
tapping the flask or, removed by the use of a sterile scraper. A volume of 2 ml medium 
was than added to neutralise the toxic effects of trypsin, and the solution was 
homogenised using a small 100 p.1 Gilson pipette. A volume of 100 p.1 of this solution 
was mixed with 100 p.1 trypan blue, and the solution was placed into a 100 jim 2 
haemocytometer and cells were counted. Dark blue cells were non-viable, bright ones 
viable. Viability and cells! 100 jim 2 were calculated. This procedure was repeated 6 
times for each condition and the means recorded. 
2.6.2 Visual count method 
Cover-slips were sterilised in a flame, then placed onto a drop of poly-l-orinithine in a 
Petri dish. A drop of poly-l-orinithine was placed on top and the cover-slips were left to 
dry. Poly-l-orinithine aids adhesion of cover-slips to the Petri-dish base and adhesion of 
the cells to the cover-slip. Cells were grown on these cover-slips for a number of days 
suitable to ensure exposure of the minerals without causing confluence, 3 days for 
132 1N1 and 7 days for U87MG. Cells were then counted using a Leica visual 
microscope with a graticule eyepiece. The number of cells visible within the graticule 
on a blindly-selected area of the cover-slip was recorded. This procedure was repeated 
6 times for each condition and the means recorded. 
2.6.3 MTT assay method 
Cells in 2 flasks were trypsinised and mixed; the cells were counted using trypan blue 
staining. A volume of I ml of the cell solution was placed into each of 6 micro 
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centrifuge tubes and centrifuged at 1500 rpm (250 g) in a 24 x 2 mL capacity bench-top 
micro-centrifuge for 3 mm.. The number of cells in a pellet was calculated as the trypan 
blue count x10 4 which gave the number of cells in 1 ml. Pellets were then re-suspended 
in 200 R1  DMEM, and 100 R1  DMEM was added to each well of a 96 (12 x 8) well 
plate, and 100 Al of the re-suspended pellet added to each well of the top row (12 wells). 
This was then mixed and 100 gl added to the next row, which was then mixed and 100 
pJ added to the next until the plate was full. A volume of 20 M1  of MTT was added to 
each well and the plate was incubated for 4 hours at 37°C. A volume of 100 il of SDS 
was then added and the plates returned to the incubator overnight. Plates were then 
placed into an Athos htIII Plate Reader, shaken for 8 seconds, and then the absorbance 
was read at a wavelength of 540 nm. This was repeated at 3 different times with 3 
different plates. A calibration graph was plotted for each cell line using the mean value 
obtained from the three calibration curves (figure 4). Error bars represent the standard 
error of the mean. 
An equal number of cells were added to each well in a 96 well plate with 100 PI of the 
relevant medium. After a relevant number of days (3 for 132 lNl and 7 for U87MG), 
the MTT assay was carried out as described above. Mean absorbance for each 
condition was taken. Cell number was then read off the calibration curve and plotted on 
a graph. 
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Figure 4. The calibration curves for the MTT cell proliferation assay. Points are mean ± 
SEMI n=3. Number of cells in each well was calculated using typan blue count, n4. 
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2.6.4 Protein Assay 
On day 7 (for 132 1N1) or 14 (for U87M0) of treatment, cultured cells were trypsinised, 
re-suspended in medium and then centri&ged at 1500 RPM (250 g) for 3 mm. The 
supematant was discarded, and the pellet was then washed in pH 7.4 Phosphate 
Buffered Saline (PBS). This was centrifuged, then the pellet was washed again and 
centrifuged for a final time. The pellet was frozen and stored. 
A protein assay was carried out using a micro-Lowry kit. Cells were suspended in 1 ml 
distilled H20 and 1 ml Lowry's solution, and left for 20 min at room temperature. A 
volume of 500 .tl Folin-Cioealteu's solution was then added, and colour was allowed to 
develop for 30 mm.. Absorbance was read at 650 nm using a Pharmacia LKB 
Novaspec II speetrophotometer. A calibration curve was plotted using protein standards 
supplied with the assay kit. Protein content of pellets was read from this graph. (Figure 
5) 
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Figure 5. The calibration curve for the protein assay. Each point is the mean of 3 assays. 
2.7 Cell staining for morphology 
Cells were grown on flame-sterilised cover slips in each medium type for 
monphological staining. The cover-slips were covered in 50% methanol for 5 mm. in 
order to fix the cells, and then washed in 75% ethanol for a further 5 mm., followed by 
distilled water for 2 mm. to remove any impurities. Cells were then stained with Harris 
Haematoxylin solution for 20 mm. followed by 1% eosin y solution for 10 mm.. Excess 
stain was washed away by submersion in increasing concentrations of ethanol, 80%, 
90% and 100% for 5 mm. each. Cover-slips were then rinsed in distilled water and 
mounted using DPX mountant and left to dry overnight. 
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2.8 Morphology 
Cells were visualised using a Leica light microscope with camera attachment and the 
Spot 4.2.3 for Windows software package. Visible processes from cells were counted 
manually. Diameters of the cell body and nucleus were measured by "drawing" straight 
lines with the mouse, on the computer screen across the desired area which the software 
then measured. Areas of the cell body and nucleus were measured by outlining the 
structures as shown on the computer screen, using the mouse. The area was then 
calculated by the software. Processes were measured by tracing along the length of the 
process on screen and the software calculated the length of line drawn. 6 separate 
randomly selected cells were measured for each parameter and averages determined. 
2.9 Electrophysiological parameters of cells. 
Cells were grown on treated cover-slips in Petri dishes. After 3 days of treatment, cell 
clusters were impaled using a glass microelectrode filled with 3 M potassium acetate 
solution. Electrodes were pulled to a resistance of 20-25 Mfl using a CFP 1.5 Amp 
glass electrode puller (heat set to 86/100, solenoid to 32/50) with 1.2 mm outer 
diameter, 0.69 mm inner diameter filamented glass tube. Petri dishes were maintained 
at a constant temperature (37 °C) by storing them on a plate connected to a hot water 
bath. When needed, dishes were placed on a Leica inverted microscope (20 x 
magnification) and cell clumps identified. 
The circuit used to measure potential difference of cell clumps is illustrated in figure 6. 
The microelectrode was filled with 3 M potassium acetate solution, and placed into a 
microelectrode holder, also filled with 3 M Potassium acetate solution in order to ensure 
a perfect electrical connection. The electrode holder was plugged into an NL102G 
Digitimer connector, connected to the oscilloscope and ground wires. The electrode 
i;i 
was lowered into cell clumps and the change in direct current voltage from the electrode 
being in the medium to the electrode being in the cell cluster was recorded. Potential 
difference was visualised using a Gould 20 MHz digital storage 0S1420 oscilloscope, 
connected to a neurolog system bridge balance and DC preamp set to lOx signal. 
Figure 6. The circuit used for electrophysiological measurements. 
Electrical "noise" from other electrical sources outside the circuit was eliminated by use 
of a Faraday cage to isolate apparatus from electrical signals within the lab and 
grounding of all equipment to the metal table top. 
2.10 Zinc uptake determination. 
The uptake of zinc for cells treated with different levels of exogenous zinc, and the 
influence of lithium treatment on this was tested. Cells grown in test media for 3 days 
were washed with HBSS and then incubated in control medium containing 5 j.xM 
Furazin-1, solubilised in DMSO, at room temperature for 1 hour. Cells were then 
washed in HBSS to reduce background fluorescence and trypsinised. A trypan blue 
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count was carried out, and number of cells per ml suspension determined. Fluorescence 
was read using the Perkin-Elmer LS50B Luminescence Spectrometer with the FLwinlab 
computer application (Perkin-Elmer). Excitation wavelength was set to 325 nm, and 
emission wavelength to 510 nm, gentle stirring, using a magnetic flea, was used to 
minimise separation of the cells from the medium. Cells were then centrifuged and the 
fluorescence of the supernatant determined to control for any background fluorescence 
not eliminated through washing. 
Fluorescence minus background over cell number was determined for each medium 
type. Furazin-1 gives a linear relationship between zinc concentration and fluorescence. 
Cells were grown on pre-treated cover-slips and incubated in fluorescence medium for 
an hour then washed and imaged using a Zeiss LSM 510 confocal microscope in order 
to observe localisation of fluorescent staining. 
2.11 Experimental protocols 
Four experiments were carried out using the above tecimiques. 
2.11.1 Experiment 1: The effects of zinc and copper on cell proliferation, and their 
interactions with lithium. 
Cells were grown in different test media for a period of time sufficient to ensure effects 
of trace minerals, without confluence of cells (3 days for 1321N1 and 7 days for 
U87MG) (section 2.5). Their proliferation was then measured by visual counting and 
by MTT assay. 
Test media with zinc and copper concentrations close to the physiological range were 
used for this experiment (section 2.3). Each group was tested with and without 1.0 
mg/L lithium supplementation. The visual counting protocol (section 2.6.2) and the 
rio: 
MTT assay (section 2.6.3) were used as an index of cell proliferation for each treatment 
group. Figure 7 illustrates the test sample arrangement for the MTT assay. Each 96-
well plate was set up with an equal number of cells in each well and the test media as 
shown. The plate reader was used to measure absorbance values for each well. These 
absorbance values were read off the calibration curve (figure 4) to yield a cell number 
for each well. The mean number of cells for each medium type was then calculated. 
A B C D E F G H I J K L 
1 Nc 1 2 3 4 5 6 7 8 9 10 11 
2 Nc 1 2 3 4 5 6 7 8 9 10 11 
3 Nc 1 2 3 4 5 6 7 8 9 10 11 
4 Nc 1 2 3 4 5 6 7 8 9 10 11 
5 Nc 1 2 3 4 5 6 7 8 9 10 11 
6 Nc 1 2 3 4 5 6 7 8 9 10 11 
7 Nc 1 2 3 4 5 6 7 8 9 10 11 
8 Nc 1 2 3 4 5 6 7 8 9 10 11 
N c denotes no cells, and it was used to control for background staining. Numbers 1-11 
denote different medium types 
Figure 7. The set-up of a 96-well plate for MTT assay. 
41 
2.11.2 Experiment 2: The effect of trace minerals on morphological and functional 
parameters. 
The influence of trace minerals with and without lithium supplementation on 
norphologicalparameters ofglial cells. 
Cells were grown in all test media used in experiment 1 for the previously determined 
period of time (see section 2.5). Cells were then stained using the Harris Haematoxylin 
method described in sections 2.7 & 2.8. Six cells from each treatment group were 
measured. 
Resting potential; afunctional parameter ofglial cells. The resting potential functional 
parameter was measured for 1321N1 cells grown in lithium supplemented and control 
medium, using the technique described in section 2.9. 
2.11.3 Experiment 3: The cytotoxicity of zinc and copper at supraphysiological levels 
and the influence of lithium on cytotoxicity. 
Cells were grown in the control medium, and media containing either 10 mWL zinc or 
10 mg/L copper. The trypan blue method (see section 2.6.1) was used at regular 
intervals (every day for 5 days for 1321N1 or every other day for 11 days for U87MG) 
to record the proliferation of cells. Counts began on day 3 of exposure to test 
conditions. Cell viability and number counts were repeated 6 times. A protein content 
analysis for cell pellets collected at the end of each growth curve was performed using 
the Micro-Lowry protein assay kit described in section 2.6.4. 
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2.11.4 Experiment 4: The effrct of the zinc and lithium concentration of the culture 
medium on cellular zinc uptake. 
Cells were grown in the zinc test media (see section 2.3) each in either the absence or 
presence of lithium supplementation. Cells were stained using the protocol described in 
section 2.10, and fluorescence recorded. Cells were also imaged using the confocal 
microscope (section 2.10) to qualitatively assess the location of zinc within the cultured 
cells. 
2.12 	 Statistical analyses 
Where possible, data are presented as mean ± standard error of the mean (SEM). Cell 
proliferation levels, cytotoxicity of supraphysiological levels of trace minerals, and 
fluorescence, were compared by 2-way ANOVA. Post-hoc tests used were Tukey and 
Bonferroni. 
The effect of lithium on cytotoxicity of trace minerals was analysed for each trace 
mineral using a one-way ANOVA, with Tukey and Bonferroni post-hoc tests. 
Cell morphology parameters (except process number) were compared using a 2-way 
ANOVA. Tukey and Bonferroni Post-hoc tests were used. 
Process numbers for morphology were compared by Kruskal-Wallis non-parametric test 
with Tukey and Bonferroni Post-hoc tests. 
Electrophysiological parameters were compared by an unpaired student's t-test (only 2 
types of medium were used). Morphological parameters of the 2 cell lines in control 
medium were compared by unpaired student's t-test (equal variances not assumed). 
In all statistical tests a value of pc0.05 was taken to be significant. 
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Where results are significantly different, characters appear on graphs. Bars not 
featuring the same character are significantly different. 
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CHAPTER 3 
RESULTS 
3.1 Experiment 1: The effects of zinc and copper on cell proliferation. 
The effects of mineral concentrations above and below the physiological range on cell 
proliferation were examined using both the visual counting method (section 1.7.2) and 
the MTT assay (section 1.7.3). Counts were performed on day 3 for the 1321N1 cells 
and day 7 for the U87MG cells. The results of this experiment are summarised in Table 
1 and graphs of proliferation are shown in figures 8-11. The graphs display mean 
values, ± SEM, n6 for visual count methods and n='8 for MTT method. Values shown 
for MTT assay results are those determined from the calibration curves for the MTT 
apparatus, as shown in figure 4. Values shown for visual counting are the number of 
cells visible in a 1cm3 graticule area. 
Many of the significant differences shown in Table 1 do not appear to be dose-related, 
as proliferation levels do not display a consistent pattern as the trace mineral 
concentration of the media increases. Lithium has some distinct significant effects in 
visual counting assay as can be clearly seen, in the graphs below. There is non-
significant effect. 
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Table 1. Proliferation trends, as observed in the following cell number plots, comparing 
two different assay methods. 
Cell line 
Treatment U87MG 1321N1 
Zinc, by visual counting Control significantly higher 0.5 mg/L & 5 mg/L zinc 
than all others (pC0.05) significantly lower than 1 
7.5 mg/L significantly lower mg/L & 7.5 mg/I. zinc 
than 1 mg/L zinc (p<0.05), (p<0.05). 
but not 0.5 mg/L or 5 mg/L 
(p=0 .059). Lithium had no significant 
Lithium had no significant overall effect on proliferation 
overall effect on proliferation (p=0.672) 
(p=0.444)  
Zinc, by MIT assay No significant differences 0.5 mgfL zinc significantly 
between treatment groups higher than control,1 mg/L, 
p=0.402. or 7.5 mg/L zinc. (p<0.05) 
7.5 mg!L zinc significantly 
lower than 5 mg/L zinc or 0.5 
mg/L zinc.(p<0.05) 
Lithium had no significant Lithium had no significant 
overall effect. overall effect, cells grown in 
lithium were not significantly 
different to each other. 
Copper, by visual counting 5 mg/L copper significantly S mg/L copper significantly 
higher than all other test higher than all other test 
groups (pc0.05). groups (p<0.05). 
1 mg/L and 0.5 mg/L copper No other significant 
were significantly lower than differences (p=0.327). 
5 mgIL copper, control, and 
0.1 mgfL copper (p<O.OS). 
Lithium had no significant 
overall effect on proliferation Lithium had no significant 
(p=0.913) overall effect on proliferation 
(p=0.692) 
Copper, by MIT assay 0.1 mg/L copper significantly Control & 0.5 mg/L copper 
higher than control or 5 mg/L significantly higher than 0.1 
copper (p<O.OS), not different mg/L, 1 mg/L & 5 mg/L 
to 0.5 mg/L copper or 1 mg/L copper. (p<0.05). 
copper (p=0.052). 
Lithium had no significant Lithium had a significant 
effect on proliferation overall inhibitory effect on 
(p=0.217) proliferation (p<0.05). Cells 
grown in lithium were not 
significantly different to each 
other (p=0.226). 
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Figure 8. Bar chart showing the proliferation of 1321N1 cells cultured in zinc test 
media. Data are mean ±SEM. n=6 (visual count) n=8 (MTT) 
1,2 
 MTT counts with different superscripts are significantly different to each other. 
Compared using 2 way ANOVA. 
a,b Visual counts with different superscripts are significantly different to each other 
Compared using 2 way ANOVA. 
Neither the visual counting nor the MTT method revealed a dose dependent relationship 
between cell proliferation and the zinc concentration of the culture medium. The 
addition of Li to the culture media had no significant effect overall (2 way ANOVA). 
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Figure 9. Bar chart showing the proliferation of 1321N1 cells cultured in copper test 
media. Data are mean thSEM. n=6 (visual count) n=8 (MTT) 
1,2 
 MTT counts with different superscripts are significantly different to each other. 
Compared using 2 way ANOVA. 
a,b Visual counts with different superscripts are significantly different to each other 
Compared using 2 way ANOVA. 
Visual counting resulted in a significant peak at 5 mg/L, however there was no evidence 
for a dose dependent effect using either the visual counting or MTT assay. The addition 
of Lithium to the test media had no overall effect on cell proliferation. 
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Figure 10. Bar chart showing the i,roliferation of 1187MG cells cultured in zinc test 
media. Data are mean ±SEM. n=6 (visual count) n8 (MTT) 
a,b Visual counts with different superscripts are significantly different to each other 
Compared using 2 way ANOVA. 
Using the visual counting method, addition of zinc to the test media resulted in an 
inhibition of cell proliferation. This was not observed using the MTT assay. The 
addition of Lithium to the culture media had no significant overall effect. 
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Figure 11. Bar chart showing the proliferation of U87MG cells cultured in copper test 
media. Data are mean ±SEM. n=6 (visual count) n8 (MTT) 
1.2 
 MTT counts with different superscripts are significantly different to each other. 
Compared using 2 way ANOVA. 
a,b Visual counts with different superscripts are significantly different to each other 
Compared using 2 way ANOVA. 
A significant increase in cell proliferation at the highest copper concentrations was 
found using the visual assay technique. Several effects of lithium are apparent, however, 
whether proliferation rises or falls with lithium treatment is random, thus yielding no 
overall significant effect. 
The MTT assay did not reveal any dose dependent responses to the copper content of 
the media. 
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There are some striking differences between the findings of the two assay techniques, 
for example, for 1321N1 cells cultured in the copper test media, the visual counting 
method indicates a significant peak at the highest dose used, while the MTT assay 
indicates a significant peak at 0.5 mgIL, one of the lowest doses. The MTT assay may 
be influenced by cellular firnctional parameters, as it is dependent on enzyme activity 
within the cell. Some fbnctional parameters were measured to see if these were 
influenced by the treatments used. Functional parameters measured were morphology 
and resting potential. 
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nucleus 
3.2 Experiment 2: The effect of trace minerals on morphological and functional 
parameters. 
3.2.1 The influence of zinc and copper, in the absence and presence of lithium 
supplementation on morphological parain eters ofglial cells. 
The different cell tines had similar morphological characteristiés; 
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Figure 12. 1321N1 cells grown in control medium morphologically stained with Harris 
haematoxylin stain (x 20 magniuication. This photograph is typical of 6 taken of 
1321N1 cells grown in each medium condition. 
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Figure 13. U87MG cells grown in control medium morphologically stained with Harris 
haematoxyjjn stain (x20 magnification). This photograph is typical of 6 taken of 
U87MG cells grown in each medium condition. 
Comparison of the morphological features of the two cell lines using a students 
Student's t-test revealed that the 1321 cells had significantly larger nuclear area 
(p=0.044) and cell body area (p=0.005) when grown in control medium (3 cells from 
each of 5 different Petri dishes for U87MG and 3 cells from each of 6 different Petri 
dishes for 132 iN! were tested). 
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Figure 14. Bar chart showing the morphological parameters of each type of cell grown 
in control medium. Data are mean ±SEM, n=6. 
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Some differences between treatment levels within cell lines were found. Lithium was 
found by ANOVA to have no significant effect on any treatment group. Numbers and 
lengths of processes were not altered in any treatment group in either cell line. Effects 
of zinc and copper on cell morphology are illustrated in tables 2 and 3, and in figures 
15-22. 
** 
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Table 2. Morpholojcal trends for cells treated with zinc. 
132 1N1 treated with zinc U87MG treated with zinc 
Number of No significant difference No significant difference between 
processes between treatment groups treatment groups (p=0.888). 
(p=0.3 12).  
Total length of No significant difference No significant difference between 
processes between treatment groups treatment groups (p'0.355) 
(2=0.071)  
Nuclear diameter Cells grown in 7.5 mgIL zinc Cells treated with 0.5 mg/L zinc 
significantly larger than those significantly larger than those in 1 
grown in 0.5 mg/L zinc and 1 mg/L, 5 mg/L and 10 mg/L. (p<0.05), 
mgIL zinc (p<0.05), but not but those in control or 7.5 mg/L zinc 
control, 5 mg/L zinc, or 10 were not significantly different to any 
mg/L zinc other treatment group. 
Nuclear area Cells grown in 7.5 mg/L zinc Cells grown in 0.5 mg/L zinc 
significantly larger than those significantly larger that those grown in 
grown in control, 0.5 mg/L 5 mg/L zinc or 10 mg/L zinc, not 
zinc, and 1 mgIL zinc, but not significantly different to control, 1 
different to 5 mg/L zinc or 10 mg/L zinc or 7.5 mgfL zinc. 
mgIL zinc. 
Cell body Cells grown in 7.5 mg/L zinc No significant differences between 
diameter significantly larger than those treatment groups. (p=0.241) 
in 0.5 mgfL zinc or 1 mgfL 
zinc. Not significantly 
different to control or 5 mg/L 
zinc 
Cell body area No significant difference Cells grown in 0.5 mg/L zinc larger 
between treatment groups than those grown in control medium, 1 
(p=0.306) mgIL zinc, 5 mg/L zinc and 10 mg/L 
zinc (pc0.05). Not significantly 
different to those grown in 7.5 mg/L 
zinc. 
Patterns for different morpholdgical parameters of cells when treated with zinc follow 
similar trends within cell lines, but are very different between cell lines. 1321N1 is 
enlarged in 0.5 mg/L zinc in several of the parameters listed above and U87MG is 
enlarged in 7.5 mgfL zinc. These trends are illustrated in figures 14 to 17, below, 6 
cells from separate Petri dishes were measured for each condition, error bars indicate 
standard error. 
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Figure 15. Bar chart showing the nuclear and cell body diameters of 1321N1 when 
treated with zinc. Data are mean ±SEM, n=6. 
a.b 
 Nuclear diameters with different superscripts are significantly different to each other. 
Compared using 2 way ANOVA. 
1,2 Cell body diameters with different superscripts are significantly different to each 
other Compared using 2 way ANOVA. 
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Figure 16. Bar chart showing the nuclear and cell body areas (um 2)of 1321N1 cells 
when treated with zinc. Data are mean ±SEM, n=6. 
a ,b Nuclear areas with different superscripts are significantly different to each other. 
Compared using 2 way ANOVA. 
2 
 Cell body areas with different superscripts are significantly different to each other 
Compared using 2 way ANOVA. 
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Figure 17. Bar chart showing nuclear and cell body diameter (urn) of U87MG cells 
when treated with zinc. Data are mean ±SEM, n=6. 
a.b 
 Nuclear diameters with different superscripts are significantly different to each other. 
Compared using 2 way ANOVA. 
2 
 Cell body diameters with different superscripts are significantly different to each 
other Compared using 2 way ANOVA. 
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Figure 18. Bar chart showing nuclear and cell body areas (urn 2) of U87MG cells when 
treated with zinc. Data are mean ±SEM, n=6. 
a .b Nuclear areas with different superscripts are significantly different to each other. 
Compared using 2 way ANOVA. 
I. 2 Cell body areas with different superscripts are significantly different to each other 
Compared using 2 way ANOVA. 
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Table 3. Morphological trends for cells treated with copper. 
132lNl treated with copper I U87MG treated with copper 
Number of No significant difference No significant difference between 
processes between treatment groups treatment groups (p=0.401) 
(p=0.073).  
Total length of No significant difference No significant difference between 
processes between treatment groups treatment groups (pO. 189). 
________________ (p=O.397)  
Nuclear diameter Cells grown in 10 mg/L copper Cells treated with 0.1 mg/L copper or 
significantly larger that those 0.5 mg/L copper significantly larger 
in control, or 0.5 mg/L copper. than those grown in control medium 
Not different to 1 mgfL (pc0.05). Cells grown in 1 mg/L 
copper, 5 mgIL copper, or 0.1 copper or 5 mgIL copper not different 
mg/L copper. to any other treatment group. 
Nuclear area Cells grown in 10 mg/L copper Cells grown in 0.1 mg/L copper 
significantly larger than all significantly larger than those grown 
other treatment groups in control or 5 mgIL copper, not 
(pc0.05). significantly larger than those grown 
____________ in 0.5 mg/L, or 1 mg/L copper. 
Cell body Cells grown in 10 mg/L copper Cells grown in 0.1 mgfL copper 
diameter significantly larger than all significantly larger than those grown 
other treatment groups in control, 0.5 mg/L copper or 5 mgIL 
(pc0.05), except 1 mg/L copper. Not significantly different to 
copper. those grown in 1 mgfL copper. 
Cell body area Cells grown in 10 mg/L copper Cells grown in 0.1 mgIL copper 
significantly larger than all significantly larger than all other 
other treatment groups treatment groups (pc0.05). 
(pc0.05).  
Patterns for different morphological parameters of cells when treated with copper 
follow similar trends within cell lines, but are very different between cell lines. 132 1N1 
is enlarged in 10 mgfL copper in several of the parameters listed above, and U87MG is 
enlarged in 0.1 mgfL copper (U87MG proliferation was too low in 10 mgIL copper for 
morphological parameter to be measured). These trends are illustrated in figures 19 to 
22, below. 
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Figure 19. Bar chart showing the nuclear and cell body diameters (um) of 132 1N1 cells 
when treated with copper. Data are mean ±SEM, n=6. 
a ,b Nuclear diameters with different superscripts are significantly different to each other. 
Compared using 2 way ANOVA. 
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Figure 20. Bar chart showing the nuclear and cell body areas (urn 2) of 1321Nl cells 
when treated with copper. Data are mean ±SEM, n6. 
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Figure 21. Bar chart showing the nuclear and cell body diameters (urn) of U87MG cells 
when treated with copper. Data are mean ±SEM, n=6. 
a,b 
 Nuclear diameters with different superscripts are significantly different to each other. 
Compared using 2 way ANOVA. 
I. 2 Cell body diameters with different superscripts are significantly different to each 
other Compared using 2 way ANOVA. 
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Figure 22. Bar chart showing the nuclear and cell body areas (um 2)of U87MG cells 
when treated with copper. Data are mean ±SEM, n=6. 
a ,b Nuclear areas with different superscripts are significantly different to each other. 
Compared using 2 way ANOVA. 
I. 2 Cell body areas with different superscripts are significantly different to each other 
Compared using 2 way ANOVA. 
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3.22 Resting potential; a functional parameter ofglial cells. 
No difference was recorded in the potential differences observed when 132N1 cells 
were cultured in control either in the presence or absence of lithium. 
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Figure 23. Histogram showing the resting potentials of 132 IN1 cells with and without 
lithium supplementation. Data are mean ±SEM, n6. 
3.3 Experiment 3: The cytotoxicity of zinc and copper at supraphysiological levels 
and the influence of lithium on cytotoxicity. 
On day 3 of exposure to trace minerals, no significant differences between cell 
proliferations were found between any of the medium types used. However, cell growth 
rates showed some significant effects (p<0.05) over a more prolonged time period. The 
data are as shown in figures 24-27. Protein content was measured to support growth 
rate data, the protein analysis data are shown in figures 28 & 29. Cell viability was also 
measured to determine whether cell division or cell death was affected in any changes 
found in the toxicity study, the viabilities are shown in figures 30- 33. 
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3.3.1 Proliferation rate of cells in supraphysiological levels of zinc or copper. 
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Figure 24. Bar chart showing the proliferation rate of 1321N1 cells cultured in 
supraphysiological levels of trace minerals. Data are mean ±SEM, n=6 and they are 
expressed as a percentage of cell proliferation in control medium. 
Analysis of the data presented in figures 24 and 25 by 2-way ANOVA and Tukey post 
hoc test revealed no significant differences between proliferation of cells in either 
Control medium and 10 rng/L zinc or control medium and 10 mg/L copper. 
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Figure 25 Bar chart showing the proliferation of 1321N1 cells cultured in 
supraphysiological levels of trace minerals with 1mfL lithium. Data are mean ±SEM, 
n=6 and they are expressed as a percentage of cell proliferation in control medium. 
Lithium significantly reduced proliferation of cells grown in control medium (p0.045) 
and zinc supplemented medium (p=0.042). The presence of lithium had no significant 
effect on cells grown in copper supplemented medium. 
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Figure 26 Bar chart showing the proliferation of U87MG cells cultured in 
supraphysiological levels of trace minerals. Data are mean ±SEM, n=6 and they are 
expressed as a percentage of cell proliferation in control medium. 
Analysis of the data presented in figure 26 by 2-way ANOVA and Tukey post hoc test 
revealed that the proliferation of cells grown in copper supplemented medium is 
significantly lower than that of cells grown in control medium, p<0.05. 
Cells grown in zinc supplemented medium show no significant change in proliferation 
compared to control, except after 14 days, at which proliferation was reduced. 
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Figure 27. Bar chart showing the proliferation of U87MG cells cultured in 
supraphysiological levels of trace minerals, with lmg/L lithium. Data are mean ±SEM, 
n=6 and they are expressed as a percentage of cell proliferation in control medium. 
The addition of lithium to the media significantly reduced the proliferation of cells 
grown in control medium (pc0.05), but not those grown in copper or zinc supplemented 
medium. 
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3.3.2 Protein content of cell pellets collected at completion of experiment 3. 
Medium type 
Figure 28. Bar chart showing the protein content of pellets collected from 1321N1 cell 
cultures. Data are mean ±SEM, n6. 
Note that there was no significant difference between protein content of cells grown in 
control medium, 10 mg/L zinc or 10 mg/L copper. Lithium had no effect on protein 
content of any group. 
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Figure 29. Histogram showing the protein content of pellets collected from U87MG cell 
cultures. Data are mean ±SEM, n=6. 
Note that: 
1) The protein content of cells grown in copper supplemented medium is significantly 
(pc0.05) lower than those grown in control medium. 
2) There was no significant difference between protein contents in zinc and control 
groups' protein content. 
3) Lithium had no significant effect on protein content of cells grown in any treatment 
group. 
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3.3.3 Viabilities of cells grown in supraplaysiological levels of zinc or copper. 
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Figure 30. Histogram showing the viabilities of 1321N1 cultured in supraphysiological 
levels of trace minerals. Data are mean ±SEM, n=6 and they are expressed as a 
percentage of cell viability. 
Note that cells grown in control medium have significantly (pc0.05) higher viability to 
cells grown in either zinc supplemented medium or copper supplemented medium. 
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Figure 31. Histogram showing the viabilities of 1321N1 cells cultured in 
supraphysiological levels of trace minerals with lmg/L lithium. Data are mean ±SEM, 
n=6 and they are expressed as a percentage of cell viability. 
Note that lithium significantly (p<0.005) reduced the viability of cells grown in each 
condition. 
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Figure 32. Histogram showing the viabilities of U87M0 cells cultured in 
sui,raphysiological levels of trace minerals. Data are mean ±SEM, n=6 and they are 
expressed as a percentage of cell viability. 
Note that: 
1) The viability of cells grown in copper supplemented medium was significantly lower 
(p<O.OS) than those grown in control medium. 
2) Cells grown in zinc supplemented medium showed no significant difference in 
viability to those grown in control medium, except after 14 days of exposure (p<0.05) 
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Figure 33. Bar chart showing the viabilities of U87MG cells cultured in 
supraphysiological levels of trace minerals with 1 mg/L lithium. Data are mean ±SEM, 
n=6 and they are expressed as a percentage of cell viability. 
ANOVA revealed that lithium had no significant effect on viability of U87MG cells 
grown in either control, copper supplemented, or zinc supplemented medium, except for 
days 5, 7 and 14 of copper treatment, where proliferation was reduced pcO.OS. 
In summary (see figures 26-33), zinc supplementation at supraphysiological levels has 
no significant effect on cell proliferation in either cell line. Lithium affected the 
proliferation of 1321N1 cells grown in zinc supplemented medium, but not U87MG 
cells grown in zinc supplemented medium. 
Copper supplementation affected U87M0 cell proliferation negatively, but the same 
effect was not seen in 1321N1. 
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Viability of cells was not always affected in the same manner as Jive cell count. 
3.4 Experiment 4: The effect of zinc concentration in medium on zinc uptake by 
the cell, and the influence of lithium on cellular zinc uptake. 
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Figure 34. Histogram showing the zinc uptake of 1321N1 cells cultured in various 
concentrations of zinc, with and without lithium. Data are mean ±SEM, n=6. 
There was no significant difference between fluorescence of cells grown in different 
concentrations of zinc, without lithium (p=0.057). 
Cells cultured in lithium had an overall significantly higher fluorescence than those 
cultured without lithium (p=0.015). This effect is particularly marked in cells grown in 
5 mgIL zinc. ANOVA analysis of the fluorescence of cells treated with lithium with 
Tukey post-hoc analysis revealed that cells grown in 5 mgIL zinc have a significantly 
higher fluorescence than those grown in control medium or 0.5 mg/L zinc, but cells 
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CHAPTER 4 
DISCUSSION 
4.1 Experiment 1. The effect of trace mineral concentration on glial cell 
proliferation 
Overall, neither the visual counting method, nor the MTT method revealed any 
consistent dose dependent effects of the addition of either zinc or copper to the culture 
medium on cell proliferation in either cell line. The addition of lithium to the culture 
media also had no significant overall effect on cell proliferation. 
There were some inconsistencies in individual data produced by the two different assay 
techniques. Visual counting methods, while quick and easily completed have inherent 
accuracy difficulties. Cultured cells tend to grow in confluent patches, thus creating a 
wide variability between visualised areas. Firstly, a large number of sections must be 
taken to ensure an accurate representation of the overall slide. Second, randomisation 
of sections must be carefully controlled in this study. Third, the sections of slide to be 
counted must be selected prior to the observer looking down the microscope in order to 
minimise researcher bias effects. Fourth, cultured cells do not always grow in a perfect 
monolayer, and many layers superimposed on top of one another are frequently seen, 
and this may create difficulty in visually identifying separate cells. Finally, the 
processes of glial cells can also intertwine causing difficulties in visualisation of 
discrete cells. 
In order to evaluate the reproducibility of the visual counting method, a simple inter- 
observer reliability test was conducted, two observers independently counted the 
number of cells visualised in a selected graticule area. This test indicated a reliability of 
'It' 
93.97% on the same sections, giving some confidence in the objectivity of the 
observers. 
The MTT assay can only be as reliable as the count methods used for the seeding of the 
cells. The assay eliminates the subjectivity inherent in methods requiring researcher 
visual counting. The assay also has the advantage of rapid throughput enabling an 
increased number of sample replicates. The primary disadvantage of the MTT assay is 
that this technique relies upon spectrophotometric absorbanee measurements which can 
be confounded by non-solubilisation of the formazan crystals in SDS. This effect can 
be reduced by shaking of the plates. The inter-assay and intra assay coefficient of 
variation of this assay was determined. The average intra-assay coefficient of variation 
was 26%, the average inter-assay coefficient of variation (calculated using the equation 
coefficient of variation = 100 (standard deviationlmean) of a set of data) was 11%. The 
calibration assays were each conducted 3-5 weeks apart, so such a low variation 
indicates a high reproducibility. Visual counting had an inter-assay coefficient of 
variation of 28%, higher than that of MIT. Visual counts were conducted on the same 
day. The high variability between trials in visual counts carried out on the same day, 
compared with MIT assays carried out weeks apart lends credence to the MTT assay 
over the visual count method, as do the objectivity of the MIT method and the closer 
agreement between the 2 cell lines with this method. 
The lack of a significant effect of trace minerals at concentrations within the 
physiological range on cell proliferation in this study is surprising, given the clear and 
important roles of both zinc and copper in cell thnction and proliferation (section 1.4 
and 1.5). Levels of zinc and copper in control medium are both below plasma levels in 
the human, therefore it was hypothesised that proliferation might be expected to 
increase as the concentration of Zn or Cu in the medium approached physiological 
Wi 
serum levels (approx 1 mg/L in serum) 77. This suggests that there may be other factors 
limiting cell proliferation, and/or that control growth media contains sufficient mineral 
concentration for optimal growth of these cell lines. 
4.2 Experiment 2: The morphological and functional parameters of cells grown in 
differing concentrations of trace minerals. 
Harris haematoxylin is the most commonly used standard stain for cell morphology 78 . 
This study revealed that the nuclear and cell body diameters and areas of the 1321Nl 
cells, were significantly (pc0.05) greater than controls when grown in 10 mgfL copper. 
This enlarged cell body and nucleus may indicate an osmotic effect of high copper 
concentrations. An inter-observer reliability test for measurement of the same cells by 2 
independent researchers produced a reliability of 86%. The primary sources of error 
include; human bias in cell selection, for ease of measurement and a prior knowledge of 
required results. This was minimised by randomly selecting are area of the cover-slip 
without looking at the cells. 
4.2.1 The resting potential of cells with or without lithium supplementation. 
Previous research has shown that the resting potential of an excitable (neural or muscle 
fibre) cell is approximately -70 my (cat motor-neurone) and greater than -70 mV 
(cancer pagarus muscle fibre cells) 71 ' 72 . Glial cells are non-excitable, their resting 
potential was found to be around -20 to -25 my, reflecting the lower resting potential of 
non-excitable cells. The addition of Li to the control medium did not significantly 
affect the resting potentials, indicating that there was no loss of membrane integrity, or 
alteration in ionic flow into and out of the cell following exposure to lithium. 
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4.3 Experiment 3: The cytotoxicity of zinc and copper at supraphysiological levels, 
and the influences of lithium on cytotoxicity. 
There is much current research into the cellular mechanisms of zinc homeostasis 79 . 
Neurotoxicity can be preceded by zinc influx from presynaptic vesicles, but that this is 
often controlled by the capture of zinc ions by metallothionine, such that toxic levels of 
zinc do not always cause apoptosis 80. Zinc-specific transporters also act in neurones to 
remove toxic levels of zinc from the intracellular space 81 , reducing the probability of 
zinc-mediated death. These systems are either damaged or saturated in most cases of 
zinc-induced neurone death 80. Neural cell ischemia can be induced by a rise in 
extracellular zinc, and this toxicity can then be reversed by introduction of a zinc 
chelating agent 82 . Whether similar controls exist for astrocytes and glial cells may be an 
interesting area for further research. Copper as a free ion is very toxic to cells owing to 
its high redox reactivity, and can be found to accumulate in astrocytes and glia, possibly 
to protect neurone cells from toxic effects 83 . Glia may not need to take up zinc as 
effectively as neurones have defined mechanisms for homeostatic control of zinc. 
Trypan Blue stain counting was used to assess the effect of lOx physiological levels of 
zinc and copper on cell number and viability after incubation in the test media for either 
7 days (1321Nl) or 14 days (U87MG). Total protein content of the cell pellet was used 
as an additional index of total cell number. 
For U87MG, the trypan blue counting method and protein analysis found no significant 
overall effect of 10 mgIL zinc on cell viability and number, however the 10 mg/L 
copper solution reduced viable cell count to 2.91% of control media on day 14 of 
measurement (figure 26) and this was accompanied by a reduction to 24.36% (figure 
32) of control viability level and a fall to 6.92% pellet protein content (figure 29) 
compared to control. Lithium was found by Trypan Blue counting to reduce the 
viability of U87MG cells grown in control medium to 87% of control, but there were no 
differences in total cell number assessed by visual counting or pellet protein content. No 
additional effect of lithium was observed in either of the trace mineral treated groups. 
The viability of 132 INI cells was reduced to 74% and 69% in cells treated with either 
10 mg/L zinc, or 10 mgIL copper, respectively (figure 30). However, there did not 
appear to be a concurrent reduction in total cell number. Lithium was found to decrease 
cell number for those cells grown in control medium and zinc supplemented medium by 
Trypan Blue counting. The viability of cells in each treatment group was reduced by 
lithium treatment, control to 41%, zinc to 77% and copper to 17% of non-lithium 
treated cells (figures 30 and 31) . However, protein analysis found no effect of lithium 
in any treatment group (figures 28 and 29). Due to the high proliferation rate of 
1321N1 cells, the proliferation study could not be continued to 14 days as U87MG was, 
it may be that given 14 days, similar effects to those seen in U87MG would emerge for 
1321N1. 
The high toxicity of copper for these cell lines is predictable by the high redox activity 
of copper, and the proposed activity of astroglia in protecting neural cells from these 
toxic effects. 83 
 The previously discussed tight regulation of intracellular zinc levels 
within neural cells82 ' 81 ' 79, may also apply to astroglial cells thus protecting them from 
zinc toxicity. Evidence for the control of zinc uptake is shown in figure 34. The 
homeostatic regulation of zinc uptake appears to be perturbed by the presence of 
lithium. 
4.3.1 Methodological issues 
The trypan blue counting method is dependent on flill trypsinisation of all cells 
Trypsin is a cytotoxic solution when cells are exposed to it for a period of time and this 
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may confound viability studies. If cells do not lift from the base of a flask after the 
specified 5 mm., they can be scraped using a sterile scraper in order to avoid toxic 
effects of trypsin. This is, however, also damaging to cells, and may also influence 
viability assays. 
The variability between trials in this part of the study is very large, and proliferation 
levels appear to differ widely between repetitions of the experiment when up to 6 weeks 
apart. Flasks of cells subcultured on the same day for the purpose of a longitudinal 
study showed lower variability than those subcultured several weeks apart. 
Four counts were taken for each flask used and the standard error between these counts 
was low. The large variation in cell count between trials may be a feature of the cell 
line, or an indication of imperceptible changes in the incubator in which cells were 
maintained between weeks, rather than a fault of the Trypan blue method of counting. 
Trypan blue is a commonly used cell proliferation assay technique, upon which many 
assay kits depend for their calibration. 
Protein assays may be a good, objective calculation of proliferation, but could easily be 
confounded by cell size, cell loss during the PBS washing phase or accidental retention 
of some supematant following washing, which with the small pellet size produced can 
affect protein concentration recorded to a large extent. 
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4.4 Experiment 4: The effect of zinc concentration in medium on zinc uptake by 
the cell, and the influence of lithium on cellular zinc uptake. 
The results from experiments 1 and 3 indicated that zinc had no significant effect on cell 
proliferation in either the I 321N1 or U87MG cell lines, however, lithium significantly 
reduced the proliferation of 1321N1 cells grown in 10 mgIL zinc, but not in U87M0 
cells grown in 10 mg/L zinc. 1321N1 cell viability was affected by treatment with 10 
mg/L zinc, but U87MG viability was not. This raises questions regarding the regulation 
of zinc uptake from the medium. Experiment 4 examined the uptake of a zinc-specific 
fluorescent probe into 132 1N1 cells. The absence of a change in either zinc or lithium 
treatment indicates that glioblastoma cells regulate zinc transport into the cell. Several 
previous studies have demonstrated the existence of cellular control of zinc 
levels79 ' 80' 81 ' 82 ' O'Hal!oran et a184 have carried out much work searching for mechanisms 
of cellular control of zinc, and they propose that zinc is carried into the cell by a zinc 
carrier ZntR, and bound to an intracellular protein (Zur). Upon saturation of Zur 
proteins within a cell, no further zinc transport is allowed into the cell. This theory 
proposes a total absence of free intracellular zinc ions, all zinc is bound to intracellular 
proteins or excreted from the cell. This tight cellular control of zinc influx may explain 
the absence of an effect of zinc concentration on cell proliferation, morphology and 
viability. 
When 132 1N1 cells are cultured in media containing both lithium and zinc, zinc uptake 
of the cells is significantly enhanced. Zinc uptake is at its highest in 5 mg/L zinc with I 
mg/L lithium (significantly higher than in control medium and in 0.5 mg/L zinc, not 
significantly different to 1 mg/L zinc or 7.5 mg/L zinc). This study indicates that the 
cellular control of zinc influx is perturbed by lithium treatment at therapeutic levels in 
132 1N1 glioblastoma cells. 
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4.5 Conclusions 
Copper showed low toxicity up to extracellular concentrations of 5 mg/L in this study, 
but higher doses (10 mg/L), had a profound effect on viability and proliferation of 
U87MG cells and a significant effect on 1321N1 cells. It is likely that the cells used in 
this study show control of copper ion influx, but that this is perturbed by high 
concentrations of copper, this hypothesis could be confirmed by use of a copper-specific 
fluorescent marker. Such a copper specific marker was not available for this study. 
Zinc showed very low toxicity levels throughout this study, the fluorescence work, 
however, indicates that this is due to cellular control of zinc influx, which may be 
perturbed by simultaneous treatment with lithium, this may warrant further study. 
Treatment with either trace mineral produced remarkably few changes in the functional 
parameters measured in this experiment. Cells treated with copper at toxic levels 
generally appeared enlarged, this may indicate that copper toxicity is initiated by an 
osmotic gradient caused by the influx of copper ions into the cell. Similar cellular 
enlargement did not occur in cells treated with toxic levels of zinc, indicating zinc may 
cause cell death by another means. 
Glioblastoma cell lines in vitro are a limited but useful model of activity of glial cells in 
vivo. Glial cells may show different reactions to trace mineral treatment, but this study 
provides an indication as to likely glial cell responses to trace mineral exposure. 
4.5.1 Methodology 
The cell count methods have different reliability, despite the large error bars shown, 
trypan blue counting is an accurate and helpful method, although practical constraints 
make this inappropriate for a large number of conditions. The protein assay has many 
conceivable flaws, but followed the trend of the trypan blue count method quite closely 
and supports the findings of this. The MTT assay has a good reproducibility and 
reliability for this application. Graticule-based visual counting is not a recommended 
proliferation assay tecimique. 
4. £2 Future research. 
The investigation of ion uptake using a fluorescent probe should be repeated in the 
U87MG cell line, and other glioblastoma lines, to determine whether this effect is 
specific to the 132 1N1 cell line, or whether it could be generalised to glioblastoma cells. 
If this effect is general, mechanisms for an inhibition of zinc influx control by lithium 
should be sought, as this may contribute further to the understanding of the method of 
action of lithium Carbonate prophylaxis. The current proposed action of lithium is 
primarily through blocking magnesium-dependent enzymes in the synthesis of inositol. 
The blocking is achieved by partially mimicking the magnesium ion on the enzyme 
receptor, thus blocking its action 25. Lithium may similarly alter the action of zinc 
specific cell membrane channels, or zinc-dependent enzymes within the cell. 
If the action of lithium on zinc uptake regulation is generalised in different cell 
populations, a clinical study of in viva serum concentrations of zinc in bipolar disorder 
patients who respond to lithium prophylaxis and those who do not may be of interest in 
the search for predictors of responsivity to lithium prophylaxis. 
A copper-specific fluorescent marker was not available to search for a similar effect in 
copper regulation, however the higher toxicity of copper found in experiment 3 implies 
that this may be less tightly controlled by the cell. Use of another, more general ion 
fluorescent marker may help to shed light on control mechanisms for copper influx and 
any effect lithium may have on this. 
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APPENDICES 
Appendix 1 
Composition of Dulbecco's Modified Ea&e's Medium, as obtained from Si2ma-
Aldrich Co. 
Constiuent J 	 Concentraion (gIL) I 	 Concentration (mM) 
INORGANIC SALTS  
CaC12•2H20 0.265 1203.397 
Fe(NO3)3•9H20 0.0001 0.247619 
MgSO4 0.09767 811.4081 
KCI 0.4 5362.052 
NaHCO3 37 44047.09 
NaCl 6.4 109514 
NaH2PO4 0.109 908.6059 
AMINO ACIDS 
 
L-Arginine•HCI 0.084 398.6711 
L-Cystine•2HCI 0.0626 322.5142 
Glycine 0.030 399.627 
L-HistidineHCl•H20 0.042 200.3817 
L-Isoleucine 0.105 800.3049 
L-Leucine 0.105 800.3049 
L-Lysine•HCI 0.146 799.1242 
L-Methionine 0.030 201.0724 
L-Phenylalanine 0.066 399.5157 
L-Serine 0.042 399.6194 
L-Threonine 0.095 797.649 
L-Tryptophan 0.016 78.35455 
L-Tyrosine•2Na•2H20 0.10379 397.3583 
L-Valine 0.094 802.7327 
VITAMINS  
Choline Chloride 0.004 28.6533 
Folic Acid 0.004 9.062075 
myo-Inositol 0.0072 39.9556 
Niacinamide 0.004 32.76003 
D-Pantothenic Acid•V2Ca 0.004 18.33181 
PyridoxineHCl 0.004 19.45525 
Riboflavin 0.0004 1.062699 
Thiamine•HCI 0.004 11.85888 
OTHER 
D-Glucose 1.0 5550.622 
Phenol RedNa 0.0159 42.24678 
Pyruvic Aci&Na 0.11 1000 
